000 01134 a2200325 4500
005 20250517140400.0
264 0 _c20181015
008 201810s 0 0 eng d
022 _a2078-2101
040 _aNLM
_beng
_cNLM
100 1 _aAnsari, Mehdi
245 0 0 _aPopulation Pharmacokinetics of Imatinib and its application to the therapeutic drug monitoring: Middle East CML population.
_h[electronic resource]
260 _bThe Gulf journal of oncology
_cSep 2016
300 _a26-36 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xpharmacokinetics
650 0 4 _aDrug Monitoring
_xmethods
650 0 4 _aHumans
650 0 4 _aImatinib Mesylate
_xpharmacokinetics
650 0 4 _aIran
650 0 4 _aLeukemia, Myelogenous, Chronic, BCR-ABL Positive
_xdrug therapy
650 0 4 _aMiddle East
650 0 4 _aPopulation Surveillance
700 1 _aKalantary-Khandani, Behjat
700 1 _aPardakhty, Abbas
700 1 _aSafavi, Moein
700 1 _aMosavi, Nabi
700 1 _aMohajeri, Ehsan
773 0 _tThe Gulf journal of oncology
_gvol. 1
_gno. 22
_gp. 26-36
999 _c26874766
_d26874766